ICU Medical: What Hospital Buyers Need to Know About the Plum 360 & Beyond

What exactly does ICU Medical make?

Short answer: a lot of the stuff that connects a patient to life-sustaining treatment. Their biggest product group is infusion systems—the Plum 360 pump, IV sets, and solutions. They're a market leader in IV solutions, which is a fancy way of saying they make a lot of the saline bags and tubing you see in hospitals.

Beyond that, they produce patient monitoring gear (think vital signs, heart rate) and some surgical devices, including energy-based tools and catheter/ablation products. They also have a vascular access line—central lines, PICC lines, that sort of thing. So it's a pretty broad portfolio, but infusion is the core.

The Plum 360: is it actually that different from other pumps?

If you're in hospital procurement, you've probably seen this question a lot. The Plum 360 is a large-volume infusion pump. Its party trick is that it can deliver two fluids simultaneously from a single pump channel. That's not unique in the market, but their implementation is pretty solid.

I compared a Plum 360 to an Alaris pump side-by-side during a trial we did in 2023. The main practical difference I found was in the set management. The Plum uses a proprietary cassette-based system that's relatively easy to prime. The downside? You're locked into their IV sets. If you're evaluating total cost, that's a big consideration—not just the pump price, but the consumables over 3-5 years.

The pump interface itself is a color touchscreen, which feels modern, but nurses I spoke to said it took about a week to become comfortable with the menu navigation. Nothing unusual compared to competitors.

Is ICU Medical just a rebranded Hospira or Smiths Medical?

Not exactly, but there's history. ICU Medical acquired Hospira's infusion pump business from Pfizer in 2017, and then bought Smiths Medical in 2022. What does that mean for you as a buyer?

It means their product line is an integration of several legacy systems. The Plum 360 was originally a Hospira product. The CADD pumps (used for ambulatory infusion, like chemotherapy) came from Smiths Medical. So if you're already invested in one of those ecosystems, ICU Medical is effectively your vendor now, whether you like it or not.

One thing I learned the hard way: don't assume compatibility between legacy sets and new pumps. During a vendor consolidation project in 2022, I discovered that a batch of older Smiths Medical cassettes didn't work with the newer Plum pumps. That mistake cost us about a week of clinical workarounds.

What's the deal with the ICU Medical 4042-2?

The 4042-2 is a specific item code—probably for an administration set or a component of the Plum system. I don't have the exact catalog number memorized, but these numeric codes are used for their IV tubing sets.

If you're searching for it, you're likely looking for a replacement part or trying to cross-reference it with a competitor's product. My advice? Call their customer service directly. Their part numbering system has changed as they've integrated the Hospira and Smiths catalogs, and sometimes online listings are outdated. I've found that getting a direct confirmation on specifications saves time vs. guessing from a PDF.

Why does ICU Medical get warning letters from the FDA?

They've had some regulatory hiccups. In 2021 and again in 2023, the FDA issued warning letters concerning their manufacturing facilities. This is a real concern for hospital procurement because a supply interruption on infusion pumps or sets is a nightmare.

I'm not gonna sugarcoat it: this does create risk. When I was evaluating a long-term contract with them in late 2023, we specifically added clauses about guaranteed supply from multiple manufacturing sites. You should be asking your rep: "Which factory is my stock coming from, and what's your backup plan if that site is shut down?"

Is it a dealbreaker? Not necessarily. Many large medical device companies have had FDA issues at some point. But it's a risk you need to price into your decision. I only believed advice to check regulatory compliance after ignoring it once and facing a delayed shipment on critical items. Don't be me.

How does ICU Medical compare to Baxter or B. Braun for pumps?

This is the million-dollar question for any hospital evaluating an infusion pump contract. I can't give you a clear winner because it depends entirely on your clinical needs and budget.

What I can tell you from my experience comparing them:

Baxter's pumps are widely used and their sets are generally cheaper—Baxter has a huge market share in IV solutions and leverages that for their pump business. B. Braun's Outlook pump is a strong competitor, especially for hospitals that want a simpler interface.

ICU Medical's Plum 360 feels more advanced in terms of the software and drug library capabilities. If you need dose-error reduction software and complex programming, it's a solid choice. If you just need a pump that reliably delivers fluids at X ml/hour, you might be overpaying for features you won't use.

The real cost difference often isn't the pump lease price anyway—it's the IV set consumption and service fees over 5-7 years. I'd suggest running a total cost analysis with your actual consumption data, not just the sticker prices.

What should I ask an ICU Medical rep before signing a contract?

From a procurement standpoint, here's my checklist after getting burned on details before:

• Compatibility: Will the new pumps work with your existing IV sets from other vendors? Don't assume.
• Consumable pricing: Get a firm price on sets and solutions with a price escalation cap (e.g., max 3% annual increase).
• Service and support: What's the average response time for a pump repair? Is there a loaner pool included?
• Training: How many nursing training hours are included in the contract? The cost of training a full hospital staff is significant.
• Regulatory compliance: Ask about the current status of any FDA warning letters and their remediation timeline.
• Termination clause: Can you terminate without penalty if they fail to meet agreed service levels? Trust me, you want this.

I'd also request a 30-day trial on a single unit before committing to a full rollout. Hands-on testing by your clinical staff will surface issues that spec sheets never will.